Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-18-349457

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d676489d8k.htm…